WELLVONE susp 750 mg/5ml 210 ml

7680535630151 CH-53563 P01AX06 08.04.3.

Active substances:

WELLVONE susp 750 mg/5ml 210 ml
WELLVONE susp 750 mg/5ml 210 ml
1 / 2
Fiches Amavita / Sun Store / Coop Vitality

Details

Product number
5356301
CPT
-
Packaging group
210
Unit
ml
Composition
atovaquonum 750 mg, alcohol benzylicus 50 mg, xanthani gummi, poloxamerum 188, saccharinum natricum corresp. natrium 0.95 mg, aromatica (Vielfrucht) cum aurantii dulcis aetheroleum, aurantii dulcis aetheroleum concentratum, propylenglycolum, alcohol benzylicus 0.66 mg, vanillinum, acetaldehydum, ethylis butyras et amylis acetas, aqua purificata q.s. ad suspensionem pro 5 ml.

Articles (1)

Wellvone, Suspension
suspension
210
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
26/02/2026
Patient information leaflet
Français
26/02/2026
Patient information leaflet
Italien
26/02/2026
Professional SmPC
Allemand
26/02/2026
Professional SmPC
Français
26/02/2026
Professional SmPC
Italien
26/02/2026

Detailed composition

Substance Quantity Type Category
atovaquonum
750.0 MG Substance Wirkstoff (Principe actif)
alcohol benzylicus
50.0 MG Substance HBESI
xanthani gummi
- Substance HNIDK
poloxamerum 188
- Substance HNIDK
saccharinum natricum
- Substance AIMDK
natrium
0.95 MG Substance HBESI
aromatica
- Substance AROMA
aurantii dulcis aetheroleum
- Substance AROMA
aurantii dulcis aetheroleum concentratum
- Substance AROMA
propylenglycolum
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
alcohol benzylicus
0.66 MG Substance HBESI
vanillinum
- Substance AIMDK
acetaldehydum
- Substance HNIDK
ethylis butyras
- Substance HNIDK
amylis acetas
- Substance HNIDK
aqua purificata
- Substance HNIDK

Reimbursement information

Public price
CHF 429.60
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 15/03/1997

Authorization holder

GlaxoSmithKline AG

6340 Baar

Authorization information

Swissmedic authorization number
53563
Drug name
Wellvone, Suspension
Galenic form
SUOR
ATC Code
P01AX06
Authorization status
Z
Dispensation category
A
First authorization
29/05/1996
Authorization expiration date
31/12/9999
IT number
08.04.3.
Domain
Human medicine
Field of application
Pneumocystis carinii Pneumonie

Packaging details

Description (FR)
WELLVONE susp 750 mg/5ml 210 ml
Description (DE)
WELLVONE Susp 750 mg/5ml 210 ml
Market launch
29/05/1996
Narcotic (BTM)
No
Buy us a coffee Explore the data